Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis

被引:0
|
作者
Cai Miaotian [1 ,2 ,3 ]
Zhu Min [1 ,2 ]
Ban Chengjun [1 ,2 ]
Su Jin [1 ,2 ]
Ye Qiao [1 ,2 ]
Liu Yan [1 ,2 ]
Zhao Wen [1 ,2 ]
Wang Chen [2 ,4 ]
Dai Huaping [1 ,2 ]
机构
[1] Department of Respiratory and Critical Care Medicine,Beijing Chao-Yang Hospital,Capital Medical University
[2] Beijing Key Laboratory of Respiratory and Pulmonary Circulation,Beijing Institute of Respiratory Medicine
[3] Beijing Youan Hospital,Capital Medical University
[4] Beijing Hospital,National Clinical Research Center for Respiratory Medicine
基金
国科技部“十一五”科技计划项目;
关键词
D O I
暂无
中图分类号
R563 [肺疾病];
学科分类号
1002 ; 100201 ;
摘要
Background Idiopathic pulmonary fibrosis(IPF) is a lethal chronic interstitial lung disease(ILD) of unknown cause and having a variable and unpredictable course. This study aimed to summarize the clinical features and follow-up outcomes and to identify potential factors useful for the assessment of prognosis in IPF.Methods Two hundred and ten patients hospitalized and diagnosed as IPF in our unit from January 1999 to June 2007 were enrolled into this study. The baseline demographic, clinical, radiologic and physiologic characteristics were summarized. Clinical follow-up data until February 2010 were collected, and the median survival time and 1-, 2-, and 5-year survival rates, as well as the influences of the summarized baseline variables on the prognosis were analyzed.Results The age at diagnosis as IPF was(64±10) years, the duration before diagnosis of 106 patients(50%) was shorter than 2 years, and 73% were males. One hundred and forty-five patients(69%) had a history of smoking with a median pack-year of 18. Eighty-nine patients(42%) had emphysema and 62 patients(29%) pulmonary arterial hypertension(PAH). One hundred and twenty-four patients were followed up, of which 99 patients died from various causes including respiratory failure related to IPF(93%). The follow-up period was(21±23) months. The median survival time was 38 months. The 1-, 2-, and 5-year survival rates were 61%, 52%, and 39%, respectively. Multivariate analysis showed clubbing, PAH, duration from initial onset to diagnosis, and forced expiratory volume in 1 second(FEV1)/forced vital capacity(FVC) were independent prognostic indicators of IPF. Conclusion IPF patients who have clubbing, PAH, a higher FEV1/FVC, and a short duration from initial onset to diagnosis have a poorer outcome.
引用
收藏
页码:1868 / 1873
相关论文
共 50 条
  • [31] A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features
    Fernandez, Bridget A.
    Fox, George
    Bhatia, Rick
    Sala, Eric
    Noble, Barbara
    Denic, Nash
    Fernandez, Dzintra
    Duguid, Nigel
    Dohey, Amanda
    Kamel, Fady
    Edwards, Laura
    Mahoney, Krista
    Stuckless, Susan
    Parfrey, Patrick S.
    Woods, Michael O.
    RESPIRATORY RESEARCH, 2012, 13
  • [32] Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
    Kim, DS
    Park, JH
    Park, BK
    Lee, JS
    Nicholson, AG
    Colby, T
    EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (01) : 143 - 150
  • [33] Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features
    Galioto, Federica
    Palmucci, Stefano
    Astuti, Giovanna M.
    Vancheri, Ada
    Distefano, Giulio
    Tiralongo, Francesco
    Libra, Alessandro
    Cusumano, Giacomo
    Basile, Antonio
    Vancheri, Carlo
    DIAGNOSTICS, 2020, 10 (07)
  • [34] Idiopathic Pulmonary Fibrosis: Epidemiology, Clinical Features, Prognosis, and Management
    Lynch, Joseph P., III
    Huynh, Richard H.
    Fishbein, Michael C.
    Saggar, Rajan
    Belperio, John A.
    Weigt, S. Sam
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (03) : 331 - 357
  • [35] Comparison of Clinical Features between Familial Idiopathic Pulmonary Fibrosis and Non-Familial Idiopathic Pulmonary Fibrosis.
    Baba, T.
    Ogura, T.
    Hagiwara, E.
    Shiihara, J.
    Sekine, A.
    Matsushima, A.
    Tsuchiya, N.
    Enomoto, T.
    Shinohara, T.
    Endo, T.
    Sogo, Y.
    Nishihira, R.
    Komatsu, S.
    Kato, T.
    Takahashi, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [36] Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes
    Salisbury, Margaret L.
    Lynch, David A.
    Van Beek, Edwin J. R.
    Kazerooni, Ella A.
    Guo, Junfeng
    Xia, Meng
    Murray, Susan
    Anstrom, Kevin J.
    Yow, Eric
    Martinez, Fernando J.
    Hoffman, Eric A.
    Flaherty, Kevin R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195 (07) : 921 - 929
  • [37] Clinical Outcomes In Patients With Acute Exacerbation Of Idiopathic Pulmonary Fibrosis Undergoing Lung Transplantation
    Nair, K. D.
    Kesavan, R.
    Barrios, R.
    Mansour, A.
    Parulekar, A.
    Loebe, M.
    LaFrancesca, S.
    Bruckner, B.
    Scheinin, S.
    Noon, G.
    Kolodziejski, P. J.
    Nguyen, J.
    Seethamraju, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [38] CLINICAL FACTORS AND OUTCOMES FOR THERAPEUTIC DELAY IN IDIOPATHIC PULMONARY FIBROSIS
    Iwanami, Naoya
    Hisata, Shu
    Yamauchi, Hiroyoshi
    Takasaki, Toshikazu
    Fujiki, Yasumaro
    Nakayama, Masayuki
    Mato, Naoko
    Suzuki, Takuji
    Bando, Masashi
    Hagiwara, Koichi
    RESPIROLOGY, 2019, 24 : 90 - 90
  • [39] A comparison of HRCT features in patients with asbestosis and idiopathic pulmonary fibrosis
    Copley, SJ
    Wells, AU
    Desai, SP
    Rubens, MB
    Musk, W
    Hansell, DM
    RADIOLOGY, 2001, 221 : 406 - 406
  • [40] Respiratory Polygraphy Features From Patients With Idiopathic Pulmonary Fibrosis
    Ernst, Glenda
    Borsini, Eduardo
    Bosio, Martin
    Decima, Tamara
    Chertcoff, Felipe
    Quadrelli, Silvia
    Salvado, Alejandro
    CHEST, 2015, 148 (04)